{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:01Z","timestamp":1787009041301,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100009980","name":"Medical University of Innsbruck","doi-asserted-by":"crossref","award":["19970"],"award-info":[{"award-number":["19970"]}],"id":[{"id":"10.13039\/501100009980","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Evotec (UK) Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/jac\/dky329","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T09:40:32Z","timestamp":1532338832000},"page":"3068-3073","source":"Crossref","is-referenced-by-count":43,"title":["Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei"],"prefix":"10.1093","volume":"73","author":[{"given":"Michaela","family":"Lackner","sequence":"first","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Birch","sequence":"additional","affiliation":[{"name":"F2G Limited, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Naschberger","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Gr\u00e4ssle","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Beckmann","sequence":"additional","affiliation":[{"name":"F2G Limited, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Warn","sequence":"additional","affiliation":[{"name":"Evotec (UK) Ltd, Macclesfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gould","sequence":"additional","affiliation":[{"name":"Evotec (UK) Ltd, Macclesfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Law","sequence":"additional","affiliation":[{"name":"F2G Limited, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Microbiology and Public Health, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"key\n\t\t\t\t20181023055620676_dky329-B1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2008.01978.x","article-title":"Changing epidemiology of systemic fungal infections","volume":"14","author":"Richardson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B3","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.cmi.2017.04.012","article-title":"A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study","volume":"23","author":"Risslegger","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B4","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1128\/JCM.41.12.5525-5529.2003","article-title":"Epidemiology of Aspergillus terreus at a university hospital","volume":"41","author":"Baddley","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","article-title":"Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience","volume":"131","author":"Lass-Fl\u00f6rl","year":"2005","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B6","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1080\/13693780802562092","article-title":"Aspergillus terreus complex","volume":"47","author":"Balajee","year":"2009","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/EC.00272-08","article-title":"Aspergillus alabamensis, a new clinically relevant species in the section Terrei","volume":"8","author":"Balajee","year":"2009","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JCM.03088-14","article-title":"Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions","volume":"53","author":"Guinea","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3114\/sim.2011.69.04","article-title":"New species in Aspergillus section Terrei","volume":"69","author":"Samson","year":"2011","journal-title":"Stud Mycol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B10","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/JCM.01582-14","article-title":"Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles","volume":"52","author":"Negri","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciu911","article-title":"Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group","volume":"60","author":"Herbrecht","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B14","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1128\/AAC.48.10.3715-3719.2004","article-title":"Antifungal therapy of murine Aspergillus terreus infection","volume":"48","author":"Graybill","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B15","doi-asserted-by":"crossref","first-page":"e0118997","DOI":"10.1371\/journal.pone.0118997","article-title":"Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing","volume":"10","author":"Kathuria","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B16","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/AAC.48.9.3217-3225.2004","article-title":"In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/infdis\/jis442","article-title":"In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration","volume":"206","author":"Arendrup","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B18","doi-asserted-by":"crossref","first-page":"e0186086","DOI":"10.1371\/journal.pone.0186086","article-title":"Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: comparison between respiratory and ear isolates","volume":"12","author":"Won","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B19","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","author":"Oliver","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B20","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/jac\/dkx177","article-title":"In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates","volume":"72","author":"Buil","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/jac\/dkx065","article-title":"Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans","volume":"72","author":"Wiederhold","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/infdis\/jix479","article-title":"Pharmacodynamics of the novel antifungal agent F901318 for acute sinopulmonary aspergillosis caused by Aspergillus flavus","volume":"217","author":"Negri","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B23","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi\u2014Second Edition: Approved Standard M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B24","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkg185","article-title":"Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B","volume":"51","author":"Warn","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B26","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/AAC.05959-11","article-title":"Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis","volume":"56","author":"Meletiadis","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/jac\/dks521","article-title":"High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia","volume":"68","author":"Lewis","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","article-title":"Azole-resistance in Aspergillus terreus and related species: an emerging problem or a rare phenomenon?","volume":"9","author":"Zoran","year":"2018","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20181023055620676_dky329-B30","doi-asserted-by":"crossref","first-page":"e01157","DOI":"10.1128\/mBio.01157-17","article-title":"Pharmacodynamics of the orotomides against Aspergillus fumigatus: new opportunities for treatment of multidrug-resistant fungal disease","volume":"8","author":"Hope","year":"2017","journal-title":"MBio"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/11\/3068\/26144769\/dky329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T01:00:55Z","timestamp":1571619655000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/11\/3068\/5078584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,8,23]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky329","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,8,23]]}}}